Organ-on-a-chip technology
Introducing the technology of ORGANOPlus Co., Ltd.

AI-powered Disease-Modeling & Pre-to-Clinical Intelligence Platform

Our platform precisely predicts preclinical and clinical drug responses ahead of time, radically reducing development risk, timelines, and costs—delivering true Preclinical-to-Clinical Intelligence for next-generation therapeutics.
원_1.png
Organoids Chip
원_2.png
AI-Powered PBPK/ADME-T Engine
원_3.png
New-Modality Ready
원_4.png
Data-Asset Monetisation

Why Organoid-Chip

Construction & Functional Verification of Biopsy‑Derived, Cell / Structure / Function‑Specific Organoid-Chip
Tech_image_01_1(0001).jpg
Tech_image_01_2.jpg

Platform Technology

Our integrated platform enables human-relevant preclinical testing with 3D organoid chips for gut, tumor, and disease-specific models—accelerating drug discovery while minimizing animal use.
Tech_image_02_1.jpg
Tech_image_02_2.jpg

Intestinal Organoid Chip Platform for Advanced Probiotic Discovery
Tech_image_03_1.jpg
Tech_image_03_2.jpg

Tech_image_04_1.jpg
Tech_image_04_2.jpg
Tech_image_04_3.jpg

Intestinal Organoid Chip Platform for Drug Repurposing
Tech_image_05_1.jpg
Tech_image_05_2.jpg

아트보드_9_사본_5.jpg
아트보드_9_사본_6.jpg

Tech_image_09_1.jpg
1234.jpg

Multi-inlet Hanging Dripper (MHD)-based Tumor Model
Tech_image_10_1.jpg
Tech_image_10_2.jpg

Tech_image_11_1.jpg
Tech_image_11_2.jpg

Tech_image_12_1.jpg
Tech_image_12_2.jpg